ACE2 and lung cancer: One previous study has demonstrated a significant increase in lung endothelial cell immunostaining for ACE2 and for serum ACE2 levels in 15 COVID-19 patients with ARDS and 13 non-COVID-19 patients with ARDS compared to control tissues from patients who had a lobectomy for lung cancer [31].